Sanaby Health Acquisition Corp. I announced the pricing of its $150 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “SANBU” Friday, October 15.
The new SPAC intends to identify promising opportunities in the healthcare industry, with a focus on digital health, life science tools and services, and innovative therapeutics. Sanaby Health Acquisition Corp. I is led by CEO Sandra Shpilberg, CFO, COO, and Secretary Mark Joing, and Chairman of the Board Timothy Zanni.
Total SPAC deal count for 2021 year-to-date is now 467. This offering is expected to close on Tuesday, October 19.
Cohen & Company Capital Markets (a division of J.V.B. Financial Group, LLC) is acting as an advisor to the Company on the transaction. BTIG, LLC is acting as the sole bookrunner for the offering. I-Bankers Securities, Inc. is acting as co-manager for the offering. BTIG is acting as the sole book running manager for the offering with I-Bankers Securities, Inc. as the co-manager. Reed Smith LLP is serving as Issuer’s Counsel with Ellenoff, Grossman & Schole LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.